European Commission opens a public consultation on improving the European system of orphan medicine designation.
作者信息
Price Richard
出版信息
Eur J Hosp Pharm. 2016 Mar;23(2):123. doi: 10.1136/ejhpharm-2016-000909.
Abstract
摘要
相似文献
1
European Commission opens a public consultation on improving the European system of orphan medicine designation.欧盟委员会就改进欧洲罕见病药品认定体系展开公众咨询。
Eur J Hosp Pharm. 2016 Mar;23(2):123. doi: 10.1136/ejhpharm-2016-000909.
2
European Commission opens consultation on orphan medicine regulation.
Eur J Hosp Pharm. 2016 Nov;23(6):368. doi: 10.1136/ejhpharm-2016-001126.
3
European commission opens consultation on EU health technology assessment co-operation.
Eur J Hosp Pharm. 2017 Jan;24(1):66-68. doi: 10.1136/ejhpharm-2016-001171.
4
President's perspective.总统视角。
Eur J Hosp Pharm. 2016 Mar;23(2):63. doi: 10.1136/ejhpharm-2016-000878. Epub 2016 Jan 29.
5
Paracetamol and pain: the kiloton problem.对乙酰氨基酚与疼痛：千吨级难题。
Eur J Hosp Pharm. 2016 Jul;23(4):187-188. doi: 10.1136/ejhpharm-2016-000952. Epub 2016 Apr 27.
6
[European incentives for orphan medicinal products].[欧洲对罕见病药品的激励措施]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 May;51(5):500-8. doi: 10.1007/s00103-008-0523-8.
7
EAHP President Joan Peppard advises members to heighten their awareness of the Falsified Medicines Directive in 2016.欧洲医院药剂师协会主席琼·佩珀德建议会员们提高对2016年《假药指令》的认识。
Eur J Hosp Pharm. 2016 Mar;23(2):124. doi: 10.1136/ejhpharm-2016-000910.
8
Establishing medical plausibility in the context of orphan medicines designation in the European Union.在欧盟孤儿药认定背景下确立医学合理性。
Orphanet J Rare Dis. 2014 Dec 5;9:175. doi: 10.1186/s13023-014-0175-8.
9
Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union.欧盟罕见病认定程序中血液系统恶性肿瘤的流行趋势变化
Orphanet J Rare Dis. 2017 Jan 21;12(1):17. doi: 10.1186/s13023-017-0567-7.
10
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012.具有肿瘤学适应症孤儿药指定的产品与用于其他罕见适应症的产品有何不同？对2002年至2012年期间授予的欧洲孤儿药指定进行的回顾性分析。
Orphanet J Rare Dis. 2017 Feb 16;12(1):36. doi: 10.1186/s13023-017-0578-4.
Zotero 插件